LawyersandSettlements.com The study, which included rosuvastatin (Crestor), did not appear to define what was considered a higher dose. “We're talking about a small effect, but it's still important information for prescribers to have when they are making their treatment choices ...
Insider Monkey (blog) Interestingly, the companies also used a similar naming situation (ending the drugs in -or) for many of the brand names as well: Pfizer Inc. (NYSE:PFE)'s Lipitor ( atorvastatin ), Merck & Co., Inc. (NYSE:MRK)'s Zocor (simvastatin), and AstraZeneca plc ...
